CERBIOS is a solid, privately held, self-financed company. It provides its stakeholders with the highest quality standards through continuous improvements, investments and innovation.
Cerbios-Pharma SA (“CERBIOS”) specializes in the development and manufacturing of chemical and biological APIs for its partners in over 60 countries worldwide, including USA, Europe, Japan, India, China. Active since 1976, CERBIOS has continuously grown and gained expertise becoming a leading supplier of Small Molecules within its Chemical Division and Large Molecules within its Biological Division.
In addition to its own APIs, CERBIOS offers CDMO exclusive services for the development and manufacturing of HPAIs as well as Biological products including monoclonal antibodies, recombinant proteins, Antibody Drug Conjugates (ADCs) and pharma probiotics for clinical trials, registration and commercial purposes.
Our long-term partners appreciate CERBIOS’ values, the commitment to communicate in an open and constructive manner, as well as its responsiveness and rapid decision making to meet their particular needs. This approach is essential in order to meet our partners’ fast changing requirements, as well as those of regulatory authorities in different countries or geographic areas.
With over 40 years of expertise, dedication and success in serving the Pharmaceutical Industry worldwide, we are proud to continue to innovate with a long-term strategy and partnership approach.
Via Figino 6
|T.: +41 91 985 63 11|
|F.: +41 91 985 63 25|
Main activities Licensing-Out ● Co-development ● Drug Substance CMO ● Other CMO Activities ●
Drug stages Pre-clinical ● Phase I - Phase III ● Registration ● Market ● Generic Plus (505B2) ● Generic ● Life cycle management ●
Therapeutic areas Cancer supportive therapy ● CNS ● Dermatology ● Gastrointestinal ● Oncology ● Ophtalmology ● Pain ● Respiratory ● Other ●
Markets CH ● EU Top 5 ● Rest of Europe ● USA and Canada ● LATAM ● MENA ● BRICS ● ASEAN ● Africa ● Australia ● Brazil ● China ● India ● Japan ● Korea ● Other ●
Drug product forms Oral (solid) ● Spray ● Topical ●
Drug substance type APIs (1-10kgs/batch) ● APIs (20-200kgs/batch) ● HPAI 10-100g/batch ● HPAI 0.2-5kgs/batch ● HPAI 6-20kgs/batch ● HPAI Cat. 3 safebridge ● Cytotoxics ● HPAI Cat. 4 safebridge ●
Other activities (non pharma) Feed Additives ● Medical Food ● Pre-formulation ●
Other CMO activities Co-development ● Contract Micronization ○ Micronization ● Pre-formulation ● Spray-Drying ● Other ●